TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.

Martin R Stockler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.